Lung cancer screening moving forward

Lung cancer screening white paper: a slippery step forward?

1) Use of evidence. The benefit of lung cancer screening is controversial. Even in the USA, the limits that Medicare put on screening are very substantial in terms of requiring registries and limiting screening centres. There are different recommendations from scientific societies based on the same evidence (age range, ex-smokers inclusion). The American Academy of Family Physicians and others ...

Moving Forward in Human Cancer Risk Assessment

BACKGROUND The current safety paradigm for assessing carcinogenic properties of drugs, cosmetics, industrial chemicals, and environmental exposures relies mainly on in vitro genotoxicity testing followed by 2-year rodent bioassays. This testing battery is extremely sensitive but has low specificity. Furthermore, rodent bioassays are associated with high costs, high animal burden, and limited pr...

Moving forward in HIV-associated cancer.

Cancer has been linked to HIV since the earliest days of the epidemic. The unusually frequent occurrence of Kaposi sarcoma (KS) among men who have sex with men (MSM) in 1981 was a sentinel observation leading to the inclusion of KS in the first AIDS case definition. More than three decades later, major research investments have led to striking advances in understanding HIV pathogenesis, with an...

Moving Forward

.......Having reached the end of my second term as editor in chief, the time has come for Micro to move forward to the next phase of its evolution. I am delighted to announce that Dr. Erik Altman from IBM Research is the new Micro EIC. Erik is an accomplished and highly respected industry architect and researcher who has held numerous leadership positions within the computing community. He has ...

Moving forward.